Xenon Pharmaceuticals Inc. SEC filings XENE

Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Apr 22, 2026
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Apr 24, 2025
DEF 14A Proxy statement Apr 26, 2024 Apr 26, 2024
DEF 14A Proxy statement Apr 27, 2023 —
DEF 14A Proxy statement Apr 28, 2022 Jun 1, 2022
DEF 14A Proxy statement Apr 28, 2021 Jun 3, 2021
DEF 14A Proxy statement Apr 28, 2020 Jun 1, 2020
DEF 14A Proxy statement Apr 29, 2019 Jun 3, 2019
DEF 14A Proxy statement Apr 27, 2018 Apr 27, 2018
DEF 14A Proxy statement Apr 27, 2017 Jun 1, 2017
DEF 14A Proxy statement Apr 27, 2016 Jun 2, 2016
DEF 14A Proxy statement Mar 30, 2015 May 4, 2015

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XENE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Burnaby
SEC filer status
Large accelerated filer
SEC CIK
1582313

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.